Target type: biologicalprocess
The directed killing of a gram-positive bacterium by a neutrophil. [GOC:add, ISBN:0781765196]
Neutrophils, a type of white blood cell, are essential in the innate immune response to gram-positive bacteria. They employ a multi-faceted arsenal to kill these pathogens, utilizing both oxidative and non-oxidative mechanisms.
**1. Recognition and Attachment:** Neutrophils recognize gram-positive bacteria through pattern recognition receptors (PRRs) on their surface, such as Toll-like receptors (TLRs) and complement receptors. These receptors bind to pathogen-associated molecular patterns (PAMPs) specific to gram-positive bacteria, including lipoteichoic acid (LTA) and peptidoglycan. This recognition triggers neutrophil activation and adhesion to the bacteria.
**2. Phagocytosis:** Activated neutrophils engulf the gram-positive bacterium through a process called phagocytosis. The cell membrane of the neutrophil surrounds the bacterium, internalizing it into a phagosome.
**3. Phagosome-Lysosome Fusion:** The phagosome then fuses with lysosomes, intracellular organelles containing a cocktail of degradative enzymes and antimicrobial agents. These include:
* **Oxidative Mechanisms:**
* **Reactive Oxygen Species (ROS):** The NADPH oxidase enzyme complex within the neutrophil generates superoxide radicals (O2-), which are further converted into other reactive oxygen species like hydrogen peroxide (H2O2) and hypochlorous acid (HOCl). These ROS damage bacterial cell membranes and proteins, leading to bacterial death.
* **Myeloperoxidase (MPO):** This enzyme uses hydrogen peroxide to generate hypochlorous acid, a highly reactive and potent antimicrobial agent that further damages bacterial components.
* **Non-Oxidative Mechanisms:**
* **Lysosomal Enzymes:** Lysosomes release a variety of enzymes, including proteases, lipases, and nucleases, that degrade bacterial proteins, lipids, and nucleic acids.
* **Defensins:** These small cationic peptides disrupt bacterial cell membranes, leading to cell lysis.
* **Neutrophil Extracellular Traps (NETs):** In response to certain pathogens, neutrophils release a web of DNA fibers decorated with antimicrobial proteins, like histones and elastase, which trap and kill bacteria.
**4. Killing and Degradation:** The combination of oxidative and non-oxidative mechanisms within the phagolysosome results in the destruction and degradation of the engulfed gram-positive bacterium.
**5. Inflammatory Response:** Neutrophils also release pro-inflammatory cytokines, such as TNF-α and IL-1β, that amplify the immune response and recruit other immune cells to the site of infection.
**Note:** The specific mechanisms and effectiveness of neutrophil-mediated killing can vary depending on the bacterial species and the host's immune status.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cathepsin G | A cathepsin G that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08311] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
3,4-dichloroisocoumarin | 3,4-dichloroisocoumarin : A member of the class of isocoumarins that is isocoumarin substituted by chloro groups at positions 3 and 4. It is a serine protease inhibitor. | isocoumarins; organochlorine compound | geroprotector; serine protease inhibitor |
triamterene | triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema. Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. | pteridines | diuretic; sodium channel blocker |
aloxistatin | aloxistatin : An L-leucine derivative that is the amide obtained by formal condensation of the carboxy group of (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylic acid with the amino group of N-(3-methylbutyl)-L-leucinamide. aloxistatin: a membrane-permeable cysteine protease inhibitor | epoxide; ethyl ester; L-leucine derivative; monocarboxylic acid amide | anticoronaviral agent; cathepsin B inhibitor |
zpck | ZPCK: alkylates histidine residue at active center of bovine chymotrypsin | ||
sivelestat | sivelestat: inhibitor of neutrophil elastase; structure given in first source | N-acylglycine; pivalate ester | |
foy 251 | 4-(4-guanidinobenzoyloxy)phenylacetic acid: RN given refers to monomethanesulfonate | ||
1-hydroxy-2-methylanthraquinone | 1-hydroxy-2-methyl-9,10-anthraquinone : A member of the class of hydroxyanthraquinones that is anthracene-9,10-dione substituted by a hydroxy group at position 1 and a methyl group at position 2. It has been isolated from the roots of Rubia yunnanensis. 1-hydroxy-2-methylanthraquinone: from root of Prismatomeris tetrandra | monohydroxyanthraquinone | plant metabolite |
pefabloc | |||
bortezomib | amino acid amide; L-phenylalanine derivative; pyrazines | antineoplastic agent; antiprotozoal drug; protease inhibitor; proteasome inhibitor | |
tosylphenylalanyl chloromethyl ketone | N-tosyl-L-phenylalanyl chloromethyl ketone : The N-tosyl derivative of L-phenylalanyl chloromethyl ketone. Tosylphenylalanyl Chloromethyl Ketone: An inhibitor of Serine Endopeptidases. Acts as alkylating agent and is known to interfere with the translation process. | alpha-chloroketone; sulfonamide | alkylating agent; serine proteinase inhibitor |
camostat mesylate | methanesulfonate salt | anti-inflammatory agent; anticoronaviral agent; antifibrinolytic drug; antihypertensive agent; antineoplastic agent; antiviral agent; serine protease inhibitor | |
benzyloxycarbonyl-phe-ala-fluormethylketone | cathepsin B inhibitor : A cysteine protease inhibitor which inhibits cathepsin B (EC 3.4.22.1). | ||
guttiferone a | guttiferone A: antibacterial from Clusiaceae family; structure in first source | ||
carfilzomib | epoxide; morpholines; tetrapeptide | antineoplastic agent; proteasome inhibitor | |
delanzomib | C-terminal boronic acid peptide; phenylpyridine; secondary alcohol; threonine derivative | antineoplastic agent; apoptosis inducer; proteasome inhibitor | |
6-(3,5-difluoroanilino)-9-(2,2-difluoroethyl)-2-purinecarbonitrile | 6-aminopurines |